PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-43

  1. 1,046 Posts.
    lightbulb Created with Sketch. 195
    Believe me mr PAR, I want to believe in this story! Its a good one.

    Unfortunately for me, after many experiences of lifestyle companies living in the shadow of potential, I cant trust this management team. I Might be missing out on gains, but from where I sit, I think they will release a few more positive announcements and then tap the market for another 100 mil, I mean, Pauls boat, house and car and travel maintenance cant be cheap. Have you seen the cash burn here!

    The drug is a pot of gold, unfortunately the share holders are forking out, ala MSB.

    Don't kill me cheerleaders, IMO only, and best of luck.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $104.9M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $161.3K 527.5K

Buyers (Bids)

No. Vol. Price($)
2 10756 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 62010 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.